
Molecular Partners AG
NASDAQ:MOLN

Intrinsic Value
The intrinsic value of one
MOLN
stock under the Base Case scenario is
16.15
USD.
Compared to the current market price of 3.52 USD,
Molecular Partners AG
is
Undervalued by 78%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Molecular Partners AG
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Molecular Partners AG
Balance Sheet Decomposition
Molecular Partners AG
Current Assets | 154.3m |
Cash & Short-Term Investments | 149.4m |
Receivables | 2.3m |
Other Current Assets | 2.5m |
Non-Current Assets | 4.2m |
PP&E | 4.2m |
Intangibles | 49k |
Free Cash Flow Analysis
Molecular Partners AG
CHF | |
Free Cash Flow | CHF |
Earnings Waterfall
Molecular Partners AG
Revenue
|
5m
CHF
|
Cost of Revenue
|
-10k
CHF
|
Gross Profit
|
5m
CHF
|
Operating Expenses
|
-66.2m
CHF
|
Operating Income
|
-61.2m
CHF
|
Other Expenses
|
7.2m
CHF
|
Net Income
|
-54m
CHF
|
MOLN Profitability Score
Profitability Due Diligence
Molecular Partners AG's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
Molecular Partners AG's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
MOLN Solvency Score
Solvency Due Diligence
Molecular Partners AG's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Score
Molecular Partners AG's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MOLN Price Targets Summary
Molecular Partners AG
According to Wall Street analysts, the average 1-year price target for
MOLN
is 13.14 USD
with a low forecast of 7.43 USD and a high forecast of 19.32 USD.
Dividends
Current shareholder yield for MOLN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MOLN
stock under the Base Case scenario is
16.15
USD.
Compared to the current market price of 3.52 USD,
Molecular Partners AG
is
Undervalued by 78%.